174 related articles for article (PubMed ID: 15464187)
1. Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein.
Frosh A; Smith LC; Jackson CJ; Linehan JM; Brandner S; Wadsworth JD; Collinge J
Lancet; 2004 Oct 2-8; 364(9441):1260-2. PubMed ID: 15464187
[TBL] [Abstract][Full Text] [Related]
2. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.
Hill AF; Butterworth RJ; Joiner S; Jackson G; Rossor MN; Thomas DJ; Frosh A; Tolley N; Bell JE; Spencer M; King A; Al-Sarraj S; Ironside JW; Lantos PL; Collinge J
Lancet; 1999 Jan; 353(9148):183-9. PubMed ID: 9923873
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples.
Hilton DA; Ghani AC; Conyers L; Edwards P; McCardle L; Ritchie D; Penney M; Hegazy D; Ironside JW
J Pathol; 2004 Jul; 203(3):733-9. PubMed ID: 15221931
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey.
Clewley JP; Kelly CM; Andrews N; Vogliqi K; Mallinson G; Kaisar M; Hilton DA; Ironside JW; Edwards P; McCardle LM; Ritchie DL; Dabaghian R; Ambrose HE; Gill ON
BMJ; 2009 May; 338():b1442. PubMed ID: 19460798
[TBL] [Abstract][Full Text] [Related]
5. Foodborne-Transmitted Prions From the Brain of Cows With Bovine Spongiform Encephalopathy Ascend in Afferent Neurons to the Simian Central Nervous System and Spread to Tonsils and Spleen at a Late Stage of the Incubation Period.
Holznagel E; Yutzy B; Kruip C; Bierke P; Schulz-Schaeffer W; Löwer J
J Infect Dis; 2015 Nov; 212(9):1459-68. PubMed ID: 25895987
[TBL] [Abstract][Full Text] [Related]
6. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.
Wadsworth JD; Joiner S; Hill AF; Campbell TA; Desbruslais M; Luthert PJ; Collinge J
Lancet; 2001 Jul; 358(9277):171-80. PubMed ID: 11476832
[TBL] [Abstract][Full Text] [Related]
7. Variant Creutzfeldt-Jakob disease.
Collinge J
Lancet; 1999 Jul; 354(9175):317-23. PubMed ID: 10440324
[TBL] [Abstract][Full Text] [Related]
8. Molecular and clinical classification of human prion disease.
Wadsworth JD; Hill AF; Beck JA; Collinge J
Br Med Bull; 2003; 66():241-54. PubMed ID: 14522862
[TBL] [Abstract][Full Text] [Related]
9. Testing for prions: a novel protocol for vCJD prevalence studies.
Glatzel M
Lancet; 2004 Oct 2-8; 364(9441):1196-7. PubMed ID: 15464165
[No Abstract] [Full Text] [Related]
10. Ethical issues in human prion diseases.
Tabrizi SJ; Elliott CL; Weissmann C
Br Med Bull; 2003; 66():305-16. PubMed ID: 14522867
[TBL] [Abstract][Full Text] [Related]
11. Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study.
Jackson GS; Burk-Rafel J; Edgeworth JA; Sicilia A; Abdilahi S; Korteweg J; Mackey J; Thomas C; Wang G; Schott JM; Mummery C; Chinnery PF; Mead S; Collinge J
JAMA Neurol; 2014 Apr; 71(4):421-8. PubMed ID: 24590363
[TBL] [Abstract][Full Text] [Related]
12. Guinea Pig Prion Protein Supports Rapid Propagation of Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease Prions.
Watts JC; Giles K; Saltzberg DJ; Dugger BN; Patel S; Oehler A; Bhardwaj S; Sali A; Prusiner SB
J Virol; 2016 Nov; 90(21):9558-9569. PubMed ID: 27440899
[TBL] [Abstract][Full Text] [Related]
13. Variant Creutzfeldt-Jakob disease with extremely low lymphoreticular deposition of prion protein.
Mead S; Wadsworth JD; Porter MC; Linehan JM; Pietkiewicz W; Jackson GS; Brandner S; Collinge J
JAMA Neurol; 2014 Mar; 71(3):340-3. PubMed ID: 24445428
[TBL] [Abstract][Full Text] [Related]
14. Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessment.
Sachse C; Groschup MH; Warzok R; Greinacher A
Eur J Haematol; 2003 Jan; 70(1):11-6. PubMed ID: 12631254
[TBL] [Abstract][Full Text] [Related]
15. [Comments on present-day spread and epidemiology of BSE and prion diseases].
Bodemer W; Kaup FJ
Gesundheitswesen; 2004 Feb; 66 Suppl 1():S21-5. PubMed ID: 14770333
[TBL] [Abstract][Full Text] [Related]
16. An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry.
Dabaghian RH; Barnard G; McConnell I; Clewley JP
J Virol Methods; 2006 Mar; 132(1-2):85-91. PubMed ID: 16219367
[TBL] [Abstract][Full Text] [Related]
17. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
[TBL] [Abstract][Full Text] [Related]
18. Rapid amplification of prions from variant Creutzfeldt-Jakob disease cerebrospinal fluid.
Barria MA; Lee A; Green AJ; Knight R; Head MW
J Pathol Clin Res; 2018 Apr; 4(2):86-92. PubMed ID: 29665324
[TBL] [Abstract][Full Text] [Related]
19. The new variant of Creutzfeldt-Jakob disease.
Zeidler M; Ironside JW
Rev Sci Tech; 2000 Apr; 19(1):98-120. PubMed ID: 11189730
[TBL] [Abstract][Full Text] [Related]
20. BSE: can we predict the future?
Plum J
Verh K Acad Geneeskd Belg; 1997; 59(5):435-49. PubMed ID: 9490927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
